Lastly, the NOS3 enzyme has been identified to play an essential role in lipolysis modulation, and obesity condition per se has profound effects on covalent modification of the NOS enzyme by insulin-dependent activation of protein kinase B [39]. The gene discussed is NOS2; the disease is obesity due to melanocortin 4 receptor deficiency.